tiprankstipranks
Trending News
More News >
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market

Werewolf Therapeutics (HOWL) Income Statement

Compare
774 Followers

Werewolf Therapeutics Income Statement

Last quarter (Q3 2025), Werewolf Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Werewolf Therapeutics's net income was $-16.37M. See Werewolf Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.89M$ 19.94M$ 16.40M$ 0.00$ 0.00
Gross Profit
$ 71.00K$ 18.18M$ 13.89M$ 0.00$ -777.00K
Operating Expenses
$ 73.67M$ 58.68M$ 69.95M$ 50.09M$ 21.63M
Depreciation and Amortization
$ 1.81M$ 1.76M$ 2.51M$ 216.00K$ 777.00K
EBITDA
$ -64.05M$ -32.47M$ -51.30M$ -49.87M$ -14.26M
Operating Income
$ -73.59M$ -40.50M$ -56.06M$ -50.09M$ -22.40M
Other Income/Expenses
$ 3.08M$ 3.13M$ 2.25M$ 104.00K$ 7.36M
Pretax Income
$ -70.52M$ -37.37M$ -53.81M$ -49.98M$ -15.04M
Net Income
$ -70.52M$ -37.37M$ -53.81M$ -49.98M$ -14.94M
Per Share Metrics
Basic EPS
$ -1.63$ -1.05$ -1.86$ -10.94$ -0.98
Diluted EPS
$ -1.63$ -1.05$ -1.86$ -10.94$ -0.98
Weighted Average Shares Outstanding
43.33M 35.65M 28.86M 18.45M 28.66M
Weighted Average Shares Outstanding (Diluted)
43.86M 35.65M 28.86M 18.45M 28.66M
Currency in USD

Werewolf Therapeutics Earnings and Revenue History